Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Gamida Cell Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
GMDA
Nasdaq
8731
https://www.gamida-cell.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Gamida Cell Ltd
Q4 2023 Gamida Cell Ltd Earnings Call
- Mar 28th, 2024 3:19 am
Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
- Mar 27th, 2024 11:00 am
Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management
- Mar 27th, 2024 11:00 am
Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial Results
- Mar 22nd, 2024 12:00 pm
Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
- Feb 23rd, 2024 1:00 pm
Gamida Cell Actively Pursuing Strategic Alternatives
- Jan 29th, 2024 11:00 am
Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
- Jan 17th, 2024 1:00 pm
Gamida Cell to Host Virtual Thought Leader Fireside Chat on December 4, 2023
- Nov 28th, 2023 1:11 am
Gamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare Conference
- Nov 20th, 2023 1:00 pm
Gamida Cell Ltd. (NASDAQ:GMDA) Q3 2023 Earnings Call Transcript
- Nov 15th, 2023 2:15 pm
Q3 2023 Gamida Cell Ltd Earnings Call
- Nov 15th, 2023 7:45 am
Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
- Nov 14th, 2023 12:00 pm
Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
- Nov 4th, 2023 12:00 pm
Gamida Cell to Report Third Quarter 2023 Financial Results
- Nov 1st, 2023 12:00 pm
Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201
- Oct 16th, 2023 8:39 pm
Gamida Cell Issues Update on Israel Operations
- Oct 9th, 2023 6:00 pm
Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa
- Oct 2nd, 2023 12:00 pm
Pleasing Signs As A Number Of Insiders Buy Gamida Cell Stock
- Sep 29th, 2023 10:10 am
Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting
- Sep 28th, 2023 12:00 pm
First Patient Receives Gamida Cell's Omisirge™ (omidubicel-onlv)
- Sep 27th, 2023 8:30 pm
Scroll